Open Access

 Our journals follow the Budapest Open Access Initiative (BOAI) funding model by the following link; https://www.budapestopenaccessinitiative.org/ (2019).

All contents of the journals freely available to readers/ authors and all institutions without a limitation period. Individuals can search, copy, print, read and download and also distribute full texts of the papers.

 In our journals, the accepted articles by peer review will be published under a Creative Commons Attribution License (CC-BY) https://creativecommons.org/licenses/by/4.0/ (2019).

 

Author fees

Please see the platform of each journal.

 

Permissions

It is the duty of the authors to get permission from copyright containers for copying photos, figures or tables that will not be published. The authors should submit the certification of permission along with the submission.

 

Disclaimer

Facts and opinions in papers published in our journals are uniquely the personal statements of respective authors. Authors are responsible for all contents in their article(s) including accuracy of the facts, statements, and citing the resources

 

Advertising Policy

None of our journals accept advertisement. We absolutely are not willing to publish any advertisement.

The journal’s policy on preprint articles

Authors are not allowed to submit preprint papers.

Publication Ethics and Malpractice Statement

Publication and authorship

All submitted manuscripts to our journals are subject to a strict peer-review process by at least two international reviewers and one local reviewer that are experts in the area each journal.

The factors that are taken into account in the review are relevance, soundness, significance, originality, readability, and language.

The possible decisions include acceptance, acceptance with revisions, or rejection.

If authors are encouraged to revise and resubmit a submission, there is no guarantee that the revised submission will be accepted.

Rejected manuscripts will not be re-reviewed.

The manuscript acceptance is constrained by such legal requirements as shall then be in force regarding libel, copyright infringement, and plagiarism.

No research can be included in more than one publication.

 

Authors' responsibilities

Authors must certify that their manuscripts are their original work.

Authors must certify that the manuscript has not previously been published elsewhere.

Authors must certify that the manuscript is not currently being considered for publication elsewhere.

Authors must participate in the peer review process.

Authors are obliged to provide retractions or corrections of mistakes.

All Authors mentioned in the paper must have significantly contributed to the research.

Authors must state that all data in the paper are real and authentic.

Authors must notify the editors of any conflicts of interest.

Authors must identify all sources used in the creation of their manuscripts.

Authors must report any errors they discover in their published papers to the editors.

Please complete the authors’ agreement form provided on the journal website and send it through email to the journal.

 

Reviewers' responsibilities

Reviewers should keep all information regarding papers confidential and treat them as privileged information.

Reviews should be conducted objectively, with no personal criticism of the author

Reviewers should express their views clearly with supporting arguments

Reviewers should identify relevant published work that has not been cited by the authors.

Reviewers should also call to the editor-in-chief's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Reviewers should not review manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

For more information, please look at the checklist for review provided on the journal website.

 

Editors' responsibilities

Editors have complete responsibility and authority to reject/accept an article.

Editors are responsible for the contents and overall quality of the publication.

Editors should always consider the needs of the authors and the readers when attempting to improve the publication.

Editors should guarantee the quality of the papers and the integrity of the academic record.

Editors should publish errata pages or make corrections when needed.

Editors should have a clear picture of a research's funding sources.

Editors should base their decisions solely on the paper's importance, originality, clarity, and relevance to the publication's scope.

Editors should not reverse their decisions nor overturn the ones of previous editors without serious reason.

Editors should preserve the anonymity of reviewers.

Editors should ensure that all research material they publish conforms to internationally accepted ethical guidelines.

Editors should only accept a paper when reasonably certain.

Editors should act if they suspect misconduct, whether a paper is published or unpublished, and make all reasonable attempts to persist in obtaining a resolution to the problem.

Editors should not reject papers based on suspicions; they should have proof of misconduct.

Editors should not allow any conflicts of interest between staff, authors, reviewers, and board members.

 

Plagiarism

Our journals are committed on publishing only original materials (materials that neither have been published elsewhere nor are under review elsewhere). All the journals are powered by the iThenticate® software, a plagiarism detector software that detects the originality of content submitted before publication. If plagiarism is recognized, we act based on flowcharts and workflows regulated by the COPE.

Plagiarism could be the following items

Direct copying the text from other articles

Copying concepts, photos, or data from other published sources

Copying  the text from the own previously published materials

 

Plagiarism Policies

If plagiarism is recognized, the manuscript will be rejected. Additionally, if plagiarism is detected after the publication of the paper, the will retract according to the COPE guidelines.

 

Duplicate Submission

Papers, which have been published elsewhere, or to be under review elsewhere, will incur duplicate submission/publication sanctions. If authors have used their own previously published study, or study that is currently under review, as the basis for a submitted manuscript, they are required to cite the previous paper and indicate how their submitted manuscript offers novel contributions beyond those of the previous work.

 

Citation Manipulation

Submitted papers that are found to include citations whose primary purpose is to increase the number of citations to a given author’s article, or to articles published in a particular journal, will incur citation manipulation sanctions.

 

Data Fabrication and Falsification

Submitted papers that are found to have either fabricated or falsified experimental results, including the manipulation of images, will incur data fabrication and falsification sanctions.

 

Improper Author Contribution or Attribution

All listed authors must have made a significant scientific contribution to the study in the paper and approved all its claims. It is important to list everyone who made a significant scientific contribution, including students and laboratory technicians.

 

Redundant Publications

Redundant publications involve the inappropriate division of study outcomes into several articles.

Process for Identification of and Dealing with Allegations of Research Misconduct

Nickan Research Institute (http://nickanrescorp.com/index.php) as the publisher and the Editor-in-Chief of each journal will take practical steps, which comprise technological and personal knowledge available to identify and block the publication of papers where research misconduct has arisen, containing citation manipulation, plagiarism, and data falsification/fabrication among others. All of our journals respect to the COPE's guidelines (http://publicationethics.org/resources/guidelines) in dealing with allegations.

 

Editorial Freedom

Our journals follow to the World Association of Medical Editors (WAME) Policy on “The Relationship between Journal Editors-in-Chief and Owners. Accordingly, the Editor-in-Chief has editorial independence and therefore has full authority over the journal’s editorial content counting how and when information is published. Editorial decisions are based solely on the validity of the papers and their importance to readers, not on the policies or commercial interests of the owner. Neither the Publisher nor other organizations interfere in the evaluation, selection, or editing of individual articles, either directly or by creating an environment in which editorial decisions are influenced.

 

CrossMark Policy

CrossMark is a multi-publisher initiative to offer a standard system for readers to find the current version of a piece of content. Through utilizing the CrossMark logo, this journal is committing to keeping the content it and notifying the readers of changes when it occurs.

All papers have the CrossMark logo in PDF. Clicking on the CrossMark logo at the top of each article in a PDF file will indicate the status of a document and may also give additional data about the document.

For more information on CrossMark, please check the CrossMark website by the following link:

https://www.crossref.org/services/crossmark/

 

 Privacy Statement

The characteristics of the authors containing names and email addresses, which are registered on the journal’s website, will be conducted only for the aims of the journal and will not be directed for any other reason.

 

Retraction

In keeping with COPE's Retraction Guidelines, a retraction will be considered by our editors if: 

It has clear evidence indicating the results are unreliable, either because of major errors (eg, miscalculation or experimental error, data fabrication, image manipulation, …)

It has plagiarism.

The findings have previously been published elsewhere without proper citation to previous sources, permission to reproduce, or justification (ie, cases of redundant publication)

There is a copyright infringement or other legal issues

It reports unethical research

It has been published solely on the basis of a compromised or manipulated peer review process

The author(s) failed to declare a major conflict of interest

Authors or editors of the journal may retract a paper. However, the final decision is made by the editors for retracting the material. If none of the authors will approve publishing a retraction, the editor/s may request such a retraction from the investigating institution, or the editor may ask for a retraction on behalf of the journal. In each condition, the editor should inform the author(s) or institution affiliated with the author(s) for publishing a retraction.

Note: After publishing a retraction, HTML version of the document will be removed from the site. Additionally, The PDF file of the article is retained unchanged; only a watermark showing the “retracted” label is placed on each page of the PDF. Finally, a link is made to the original article.

 

 

Search to Nickan website

Site Traffic

Today14
Yesterday89
This week331
This month2412
Total235954

Friday, 27 January 2023 05:40

The theme of World Hypertension Day 2014: Know your Blood Pressure

Firstly World Hypertension Day inaugurated in May 2005 and has become an annual event ever since. The aim of the World Hypertension Day is to promote public alertness of high blood pressure and to promote citizens of all countries to prevent and control this silent killer, the modern epidemic.World Hypertension Day was initiated firstly by the World Hypertension League.High blood pressure (hypertension) is considered as the silent killer since it has no apparent symptoms. Investigations show that the disease involves more than 1.5 billion people global, and around seven million people die every year from hypertension. 

Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD)

The definition of CKD-MBD is different than the previously recognized as "renal osteodystrophy", and it refers to a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following:
•Abnormalities of calcium, phosphorus, parathyroid hormone (PTH), or vitamin D metabolism.
•Abnormalities in bone turnover, mineralization, volume, linear growth, or strenght.
•Vascular or other soft-tissue calcification.
The term "renal osteodystrophy" is now limited to an alteration of bone morphology in patients with CKD, and it is one measure of the skeletal component of the systemic disorder of CKD-MBD that is quantifiable by histomorphometry of bone biopsy.

 

World Kidney Day 2014:chronic kidney disease and aging

World Kidney Day (WKD) is a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF).Seven years on from the first campaign, World Kidney Day (WKD) has turned into a global phenomenon. On March 13, 2014, medical professionals, government officials, the general public, celebrities and patients will take action locally.
Implication for health policy/practice/research/medical education
In 2014 World Kidney Day (WKD) will focus on chronic kidney disease and aging.The mission of WKD is to raise awareness so that everyone cares for their kidneys and, if appropriate, check to assess if they are at risk for kidney disease. Prevention of kidney disease, early detection, and subsequent kidney protection are critical aims for World Kidney Day.
Our research group is working on the below projects
1-Oxford classification in Iranian IgA nephropathy patients [Renal pathology unite of Dr. Baradaranlaboratory, Isfahan, Iran].
2- Significance of C4d deposits in IgA nephropathy [Renal pathology unite of Dr. Baradaran laboratory, Isfahan, Iran].
3-Renal tubular cell protection by herbal anti-oxidants [Medical Plants Research Center; Shahrekord University of Medical Sciences, Shahrekord, Iran]
4-R229Q Polymorphism of NPHS2 Gene in Patients with Late-Onset Steroid-Resistance Nephrotic Syndrome [Chronic Kidney Disease Research Center; Tabriz University of Medical Sciences,Tabriz, Iran]

Recently Published Papers
Baradaran A. Antiphospholipid syndrome-associated nephropathy; a nephropathy needs classification. J Nephropharmacol. 2012; 1(1):7-9.
Implication for health policy/practice/research/medical education
A suggested classification for antiphospholipid syndrome-associated nephropathy, should be simple and practical. However, the suggestion of a new classification for antiphospholipid syndrome-associated nephropathy will involve a magnificent amount of work and will necessitate a working group, hence, more studies on this topic is suggested.

Nasri H. Antiphospholipid syndrome-associated nephropathy: Current concepts . J Ren Inj Prev 2013; 2(1): 1-2.
Implication for health policy/practice/research/medical education
Renal pathologists and nephrologists should be aware of the morphologic characteristics of APS-nephropathy when they reviewbiopsies of lupus nephropathy patients, especially those with positive antiphospholipid antibodies.

Mubarak M, Nasri H.What nephrolopathologists needto know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions? J Nephropathology. 2014; 3(1): 4-8.
Implication for health policy/practice/research/medical education
There is sufficient epidemiological, clinical and histopathological evidence to show that antiphospholipid syndrome-associated nephropathy is a distinctive lesion caused by antiphospholipid antibodies in patients with different forms of antiphospholipid syndrome. It is now time to devise a classification for an accurate diagnosis and prognostication of the disease.